dose placebo controlled

Related by string. * DO Se . Doses . DOSE . DOSES : mg kg dose . label dose escalation . tolerated dose MTD . dose escalation study / placebos . Placebos . Placebo : placebo controlled clinical trials . blind placebo controlled . double blind placebo / controlling . controller . Controller : randomized controlled trial . obtaining controlled substance . randomized controlled trials * *

Related by context. Frequent words. (Click for all words.) 59 placebo controlled 58 dose regimens 57 dose escalation study 57 dosing 56 randomized placebo controlled 56 dosing schedules 55 blind randomized 55 dosing regimens 55 subcutaneous injections 55 blind randomized placebo 55 phase 2a 55 dose cohorts 55 events AEs 54 double blind placebo 54 dose escalation trial 53 dosing regimen 53 blind placebo controlled 53 prospective randomized 53 multicentre 52 dose escalation 52 Phase 2b study 52 Phase 1b 52 mg dose 52 multicenter randomized double 52 placebo controlled trials 52 Phase 1a 51 multicenter 51 rotigotine 51 randomized controlled 51 Phase IIa trial 51 label dose escalation 51 anticoagulation therapy 51 dose regimen 51 Phase 1b trial 51 randomized 51 randomized double 51 Phase IIa clinical 51 citalopram 50 Phase 2a clinical 50 mg BID 50 phase IIa 50 intravenous doses 50 blinded placebo controlled 50 Phase 1b clinical 50 single ascending dose 50 Phase 2b 49 pharmacokinetic profile 49 dose limiting toxicities 49 PROMACTA 49 intravenous infusions 49 noninferiority 49 esomeprazole 49 teduglutide 49 plus ribavirin 49 tolerability 49 pharmacodynamics 49 multiple ascending dose 49 Phase 2a trial 49 abatacept 49 confirmatory Phase III 49 Phase 2b clinical 49 retinoid 48 bosentan 48 mesalamine 48 safety tolerability pharmacokinetics 48 epoetin alfa 48 tamoxifen therapy 48 FOLFIRI 48 multicenter clinical 48 Phase 2b trial 48 titration 48 adalimumab 48 diabetic neuropathic pain 48 randomized #:# 48 randomized Phase III 48 Phase 2a 48 randomized clinical trials 48 pramipexole 48 phase IIb 48 events SAEs 48 safety tolerability 48 lacosamide 48 pharmacokinetics 48 n = 48 randomized clinical 48 basal insulin 48 TAXUS stent 48 peginterferon alfa 2b 48 bronchial thermoplasty 48 Phase Ib 47 dual antiplatelet therapy 47 orally bioavailable 47 ketoconazole 47 mg doses 47 mcg kg 47 budesonide 47 oral dosing 47 intravenously administered 47 IPX# 47 mg mL 47 Torisel

Back to home page